Conversion Right Triggered For LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., Jul 01, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and

LabCorp is Scheduled to Present at the William Blair & Company 30th Annual Growth Stock Conference

BURLINGTON, N.C., Jun 09, 2010 (BUSINESS WIRE) --Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the William Blair & Company 30th Annual Growth Stock Conference in Chicago, IL.

LabCorp(R) Scheduled to Webcast Its Annual Meeting of Stockholders

BURLINGTON, N.C., May 10, 2010 (BUSINESS WIRE) --Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that its Annual Meeting of Stockholders will be webcast live beginning May 12, 2010 at 9:00 a.m. Eastern Time via the Company Web site at www.labcorp.com.

LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2010 Health Care Conference

BURLINGTON, N.C., May 06, 2010 (BUSINESS WIRE) --Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Bank of America Merrill Lynch Health Care Conference in New York, NY.

Laboratory Corporation of America(R) Holdings Announces 2010 First Quarter Results

3.3% Revenue Growth, Despite Severe Weather, Drives Adjusted EPS of $1.30 BURLINGTON, N.C., Apr 21, 2010 (BUSINESS WIRE) --Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter ended March 31, 2010.

Duke, LabCorp Combine Forces to Create The Biomarker Factory

DURHAM, N.C. & BURLINGTON, N.C., Apr 20, 2010 (BUSINESS WIRE) --Duke University Medical Center and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today the formation of a joint venture to commercialize new biomarkers. The new entity is designed to speed the

Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., Apr 06, 2010 (BUSINESS WIRE) --Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

BURLINGTON, N.C., Mar 26, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that for the period of March 12, 2010 to September 11, 2010, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms

LabCorp is the First National Laboratory to Offer Customers a 21-Marker Genetic Analysis in Combination with a Double-Blind Process on Every Sample for Parentage/Relationship Testing

BURLINGTON, N.C., Mar 26, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that it is the first national laboratory to offer customers a 21-marker genetic analysis in combination with a double-blind process for parentage/relationship

LabCorp is Scheduled to Present at the Barclays Capital 2010 Global Healthcare Conference

BURLINGTON, N.C., Mar 16, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Barclays Capital 2010 Global Healthcare Conference in Miami Beach, FL.